Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma
© Cheng et al.; licensee BioMed Central Ltd. 2013
Received: 5 April 2013
Accepted: 25 September 2013
Published: 27 September 2013
A few reports suggested that low levels of Wnt signaling might drive cell reprogramming, but these studies could not establish a clear relationship between Wnt signaling and self-renewal networks. There are ongoing debates as to whether and how the Wnt/β-catenin signaling is involved in the control of pluripotency gene networks. Additionally, whether physiological β-catenin signaling generates stem-like cells through interactions with other pathways is as yet unclear. The nasopharyngeal carcinoma HONE1 cells have low expression of β-catenin and wild-type expression of p53, which provided a possibility to study regulatory mechanism of stemness networks induced by physiological levels of Wnt signaling in these cells.
Introduction of increased β-catenin signaling, haploid expression of β-catenin under control by its natural regulators in transferred chromosome 3, resulted in activation of Wnt/β-catenin networks and dedifferentiation in HONE1 hybrid cell lines, but not in esophageal carcinoma SLMT1 hybrid cells that had high levels of endogenous β-catenin expression. HONE1 hybrid cells displayed stem cell-like properties, including enhancement of CD24+ and CD44+ populations and generation of spheres that were not observed in parental HONE1 cells. Signaling cascades were detected in HONE1 hybrid cells, including activation of p53- and RB1-mediated tumor suppressor pathways, up-regulation of Nanog-, Oct4-, Sox2-, and Klf4-mediated pluripotency networks, and altered E-cadherin expression in both in vitro and in vivo assays. qPCR array analyses further revealed interactions of physiological Wnt/β-catenin signaling with other pathways such as epithelial-mesenchymal transition, TGF-β, Activin, BMPR, FGFR2, and LIFR- and IL6ST-mediated cell self-renewal networks. Using β-catenin shRNA inhibitory assays, a dominant role for β-catenin in these cellular network activities was observed. The expression of cell surface markers such as CD9, CD24, CD44, CD90, and CD133 in generated spheres was progressively up-regulated compared to HONE1 hybrid cells. Thirty-four up-regulated components of the Wnt pathway were identified in these spheres.
Wnt/β-catenin signaling regulates self-renewal networks and plays a central role in the control of pluripotency genes, tumor suppressive pathways and expression of cancer stem cell markers. This current study provides a novel platform to investigate the interaction of physiological Wnt/β-catenin signaling with stemness transition networks.
KeywordsPhysiological Wnt/β-catenin signaling Nasopharyngeal carcinoma Self-renewal network Chromosome 3 transfer Stemness transition Tumor suppressor genes Cancer stem cell markers
Multiple groups have shown that different dosage levels of Wnt signaling contribute to distinct cellular activities such as reprogramming, differentiation, tumorigenesis, and epithelial-mesenchymal transition (EMT) events [1–4]. Inappropriate activation of components of this signaling pathway has been observed in some human cancers and differentiating stem cells, in which high levels of Wnt signaling were often detected [1, 4–8]. Therefore, Wnt signaling has multiple functions in cell fate determination and is involved in generation of cancer stem cells (CSCs). However, there are unresolved issues for the role of Wnt/β-catenin signaling in the regulation of either self-renewal or differentiation networks in human cells [4, 5, 7, 9, 10].
Nasopharyngeal carcinoma (NPC) is a unique cancer, which is particularly prevalent among the southern Chinese, but rare in most other areas around the world [11, 12]. Unlike other common tumors, how Wnt signaling influences NPC and crosstalks to other networks to affect cell differentiation and growth, including regulation of CSC markers and EMT events, is unknown. NPC was reported to have an infrequent mutation of tumor suppressor gene (TSG) p53 and wild-type RB1 expression [11–14]; they both play critical roles in the control of the reprogramming process, self-renewal, and other cell fate determinations [15–17]. Wnt signaling interacts with p53 signaling [18–20] and usually acts in a dosage-dependent and tissue-specific manner for many cellular processes [1, 21–26]. Therefore, it is possible to reveal novel findings by exploring the regulatory mechanism of Wnt signaling in wild-type p53 expressing tumors such as with NPC HONE1 cells.
We previously established several microcell hybrid cell (MCH) lines derived from HONE1 cells containing a transferred copy of chromosome 3 . Because a physiological or basic level of Wnt signaling acts as a determinant factor in the regulation of stem cells and self-renewing tissues [3, 25, 27, 28] and HONE1 cells have very low endogenous expression of β-catenin, a major mediator of Wnt signaling, we hypothesized that introduction of another copy of the β-catenin gene (CTNNB1) via single copy transfer of chromosome 3 may generate physiological levels of β-catenin signaling due to the haploid level of expression of the transferred genes under control by their natural regulators. This approach differs from gene transfection studies that often cause artificial overexpression of the transferred genes . In many cancer cells, stem cell-related genes are often expressed. Exogenous β-catenin signaling may regulate these endogenous signaling networks, thus changing the direction of cellular differentiation. Additionally, p53, RB1, or other possible TSGs, often serve as negative barriers for the reprogramming and self-renewal processes [15, 16]. Delicate control of relevant signaling activities may drive cells into a more de-differentiated status, revealing signaling regulatory mechanisms during the stemness transition process, a series of regulatory relationships that are not fully understood in human cells.
It is important to determine what critical role β-catenin plays in the transferred chromosome by examining the relevant network activities in recipient cells. It is well-accepted now that Wnt/β-catenin signaling interacts with many other signaling networks such as pluripotency, cadherins, EMT, transforming growth factor-β (TGF-β), fibroblast growth factor (FGF), and TSG signaling [1, 8, 15, 16, 26, 29, 30]. If Wnt/β-catenin signaling is activated, these relevant network activities are expected to be detected in treated cells. For example, altered expression of E-cadherin and EMT markers should be found in these cells. Therefore, whether Wnt signaling, initiated at a basic and physiological level, is able to induce other signaling pathways during the progress of stemness transition, or to generate stem-like cells from human cancer cells, such as NPC, is the focus of this study.
Monochromosome 3 transfer confers physiological increases of β-catenin that up-regulates expression of core stem cell genes
Significant expression of pluripotency genes, Nanog, Oct4, and Klf4, at the RNA level was detected in HONE1 hybrid cells compared to parental HONE1 cells. Both HONE1 and mouse MCH903.1 cells show endogenous expression of human Sox2 gene, but in HONE1 hybrid cells this gene was up-regulated and had similar expression levels as seen in H7 cells (Figure 1A).
The increased level of β-catenin protein accumulating around membranes was clearly detected in the majority of hybrid cells compared to parental HONE1 cells by immunofluorescence staining (Figure 1B). As expected, up-regulated protein levels of β-catenin, Axin2, Nanog, and Oct4 were detected by Western blot analyses (Figure 1C). Compared with parental HONE1 cells, E-cadherin was up-regulated and N-cadherin was down-regulated in the HONE1 hybrid cells.
Enhanced Wnt/TCF/LEF network activity is maintained in vivo
A luciferase assay was performed using a Wnt/TCF reporter plasmid that carries a large array of Wnt response elements and is, therefore, a sensitive reporter of Wnt signals. As shown in Figure 1D, transient transfection of the superTOPGAL reporter detected an increased level of Wnt signaling by approximately 70-fold in HONE1 hybrid cells.
Immunohistochemical staining of the xenograft tumors demonstrated that β-catenin, E-cadherin, and Cyclin D1, the target of Wnt signaling, were strongly up-regulated in tumor segregants (TSs) derived from HONE1 hybrids, as compared with control tumors from the parental HONE1 and MCH4.5-2TS cells. Both β-catenin and E-cadherin proteins clearly accumulated at the membrane (Figure 1E), consistent with the pattern shown in Figure 1B cultured cells.
It has long been known that some regions of transferred chromosomes in TSs are selectively lost during tumor growth and the expression of relevant exogenous genes reverts back to levels similar to parental HONE1 cells [11, 12, 32–34]. Xenograft tumors derived from HONE1 hybrid cells were, therefore, analyzed for β-catenin expression (Figure 1F). For three of the HONE1 hybrid tumor sets (MCH4.5-1TS/4.6-1TS/4.6-2TS), increased β-catenin levels were evident as well as increased levels of endogenous stem cell genes Nanog and Oct4, compared to corresponding hybrid cells. A fourth hybrid cell line tumor, MCH4.5-2TS (see Figure 1E), did not show up-regulated expression of exogenous β-catenin and also did not have increased expression of Nanog and Oct4.
Physiological expression of exogenous β-catenin is essential for the up-regulation of the endogenous core stem cell network
Figure 2C shows that expression of β-catenin, E-cadherin, Sox2, Zeb1, and Fn1 proteins were clearly decreased in both β-catenin shRNA-treated cell lines. The inhibited expression of Oct4 was seen in MCH4.6(4), and inhibition of Klf4 was detected in MCH4.5(5), but no obvious expression change was detected for N-cadherin and Nanog. These results suggest that β-catenin signaling in HONE1 hybrid cells is involved in both stemness and EMT networks.
HONE1 hybrid cells are poorly differentiated and exhibit stem cell-like properties
Since CSC markers, CD24 and CD44, are commonly expressed in many stem-like cells, we investigated expression changes of these two markers by FACS analysis. CD24+, CD44+, and CD24+/CD44+ populations were markedly increased from 23% to 53.2%, 35.7% to 77.9%, and 42.7% to 77.2%, respectively, in HONE1 hybrid cells compared to parental HONE1 cells (Figure 3B).
Physiological Wnt levels trigger multiple signaling activities during the regulation of stem cell gene networks
The exogenous copy of β-catenin in HONE1 hybrid cells induced signaling cascades involved in multiple pathways such as Wnt, TGF-β superfamily containing BMP and Activin receptors, pluripotency maintenance, and FGF signaling (Figure 4B). For Wnt signaling, enhanced expression of the non-canonical NFAT family and Wnt receptors, FZD3, FZD5, and FZD6, was detected in these cells. However, the Stem Cell Signaling Array did not detect significant changes of signals from Hedgehog and Notch pathways (Additional file 1: Table S1).
BIO activation of Wnt signaling generates similar signaling activities as induced by chromosome 3 transfer in HONE1 cells
The GSK-3-specific inhibitor, Bromoindirubin-3’-oxime (BIO), activates Wnt signaling in stem cells and somatic cells [5, 10, 27, 35] and this small molecule was, therefore, used to treat parental HONE1 cells to determine whether it had an effect on core stem gene signaling networks, similar to that seen in the HONE1 hybrid cells. As shown in Figure 4C, 5 μM BIO treatment induced the highest mRNA expression of β-catenin and Axin2. BIO treatment in HONE1 cells up-regulated mRNA expression of endogenous stem cell genes, Nanog and Oct4, and EMT markers and regulators such as Twist, Snail, Cyclin D1, Slug, Fn1, and E-cadherin. BIO treatment also caused an up-regulation of N-cadherin in HONE1 cells, suggesting that BIO treatment does not fully mimic chromosome 3 transfer effects of inducing physiological signaling in HONE1 cells. Bio-induced β-catenin accumulation was mainly detected at the membrane in treated cells (Figure 4D).
Chromosome 3 transfer does not affect cells with high levels of endogenous β-catenin expression
To determine whether physiological β-catenin signaling might regulate other human cells, esophageal carcinoma SLMT1 cells were examined . The endogenous levels of β-catenin expression in SLMT1 were higher than that of HONE1 cells, likely due to an alternative transcript of β-catenin gene in exons 3/5 in SLMT1 cell observed by RT-PCR and sequencing analyses (data not shown). The expressions of both β-catenin and c-Myc mRNAs remain unchanged in SLMT1 hybrid cells, MCH3.11/3.22 , with an introduced copy of chromosome 3, compared with their parental SLMT1 cells (Figure 5B). Nanog and Oct4 protein expression was also unaltered in SLMT1-derived hybrid cells (Figure 5C).
Tumor suppressor gene-mediated pathways are activated in HONE1 hybrid cells
Since tumor suppression pathways were activated in HONE1 hybrid cells due to the up-regulation of Wnt/β-catenin signaling, it may affect growth ability of cells. To test these possibilities, MTT and colony formation assays in matrigel were performed with both stable scramble and β-catenin shRNA-infected HONE1 hybrid cells. The results indicated that tumor cell growth was inhibited by the knockdown of Wnt/β-catenin signaling in these cells (Figures 6B and 6C), reflecting that activation of tumor suppressive signaling has limited influence to control cell growth in HONE1 hybrid cells. However, Wnt/β-catenin signaling may stimulate cell growth during stemness transition process.
Wnt signaling and stemness network activities are progressively up-regulated in sphere-forming cells
Consistent with findings obtained from Stem Cell Signaling Array analysis (Figure 4A), many Wnt pathway components were activated, including both those in canonical and non-canonical signaling. In spheres, LEF1 was further increased 23-fold, compared to hybrid cells. Other markedly up-regulated genes are DKK1 (23.5-fold), FZD6 (29.7-fold), Wnt11 (34.9-fold), and FBXW2 (36.8-fold). Additionally, expression of some components of Wnt signaling, such as GSK3A (−9.9-fold) and the TLE repressor AES (−9.6-fold), were clearly inhibited in these spheres, as seen in Figures 7B and 7C.
Wnt signaling plays a substantial role in the control of development of several types of tissues through a dosage-dependent fashion. These regulated cells include crypt progenitor [28, 37], hair follicle , and hematopoietic stem cells . All these observations suggest that Wnt signaling is a dominant force in the control of proliferation of progenitor or stem cells. Our data further suggest that basic, moderate, physiological levels of Wnt signaling are sufficient for these cellular processes . To investigate the hypothesized role of Wnt signaling in the regulation of stemness networks in human cells, HONE1, SLMT1, and their hybrid cell lines were used. As expected, strong activation of endogenous tumor suppressors p53, RB1, and WT1 was detected in HONE1 hybrid cells, indicating that genomic integrity controlled by multiple tumor suppressor pathways within the parental HONE1 cells may be a key factor for maintaining a balanced environment to keep a low level of β-catenin expression [18–20].
Consistent with findings of both components of Wnt pathways and the core stem cell network being expressed or up-regulated in HONE1 hybrid cells, we found that the Wnt signal was clearly increased in HONE1 hybrid cells, as compared with untreated HONE1 cells. These in vitro observations were further confirmed in vivo with animal studies, indicating that there was consistent, up-regulated Wnt/β-catenin signaling in HONE1 hybrid cells.
To exclude the possibility that genes other than β-catenin on transferred chromosome 3 induced Wnt signaling in HONE1 hybrid cells, we specifically silenced β-catenin expression using β-catenin shRNA in these hybrid cells. Following the inhibition of β-catenin, expression of core stem cell genes and EMT markers was also decreased in the treated hybrid cells. These observations strongly indicate that β-catenin signaling, introduced by chromosome 3 transfer, is a dominant force in the regulation of both stemness and EMT networks in HONE1 cells, an expression pattern seen in other tissues [28, 30, 37–39].
Both chromosome 3 transfer and BIO treatment in HONE1 cells regulated EMT genes or its regulators. However, BIO only had similar, not identical biological effects as the chromosome 3 transfer, as evident in the control of cadherin switching. The Wnt signal controlling these EMT and cadherin networks was evidenced by the fact that β-catenin protein accumulated at the membranes, as seen in BIO-treated cells, hybrids with transferred chromosome 3, and recent stemness studies . This may be another regulatory process for entry control of free β-catenin into the nucleus, but the detailed mechanism of nuclear localization of β-catenin and the critical role E-cadherin plays in these processes are still not fully understood [8, 9, 21, 29, 41, 42].
The qPCR Array results confirmed that physiological β-catenin signaling triggered signals through additional pathways including pluripotency maintenance, FGF, and TGF-β superfamily signaling in HONE1 hybrid cells. For example, Smad2/5/9 and TGF-β receptors were clearly activated, which confirms previous reports that the TGF-β signaling pathway is associated with the pluripotency gene network and the EMT process [30, 41]. Many embryonic development genes such as Activin receptor, ACVR2A, were activated following the introduction of physiological β-catenin signaling in treated cells. This suggests that there are additional signals such as Activin that develop during culture and may serve to drive the reprogramming or cell self-renewal processes induced by Wnt signaling. It is also notable that the LIFR- and IL6ST-mediated pluripotency maintenance pathways, as well as BMP receptors and Smad families, were activated in HONE1 hybrid cells. Since these signals have well-known links to self-renewal programs, their increased expression provides additional evidence that physiological Wnt/β-catenin signaling is involved in the regulation of the cell self-renewal networks [4, 5, 8, 17, 43].
The stemness transition of HONE1 cells, driven by physiological Wnt/β-catenin signaling, appears to be a progressive process leading to a de-differentiated state in spheres, as demonstrated by analysis of up-regulated expression of core stem cell genes. Furthermore, genes that encode surface markers, such as CD9, CD24, CD44, CD90, and CD133, in spheres were expressed or clearly up-regulated compared to hybrid cells. Many Wnt signaling components in sphere-forming cells were identified as being involved in this stemness transition process, compared to hybrid cells. More than two-fold up-regulation of expression was detected in 34 genes, which included canonical, non-canonical, and Wnt/Ca+2 pathways.
These studies demonstrate that both dosage levels of β-catenin signaling and genetic background of tissues play critical roles in the regulation of self-renewal networks in human cells. There are very limited methods to explore physiological levels of Wnt/β-catenin signaling in current biology studies and the results of these studies indicate that haploid levels of expression of transferred β-catenin can induce signaling cascades that include multiple known pathways associated with reprogramming and self-renewal processes. Appropriate Wnt signaling may drive cancer cells into a progressive de-differentiated state, which generates expression profiles for exposure of the regulatory mechanism in stemness transition. These novel results clarify the relationships that are still controversial and rather unclear at present among Wnt signaling, stemness networks, EMT events, TSG pathways and expression of common cancer stem cell surface markers. These findings shed new light on a variety of cellular processes never before associated with physiological levels of β-catenin signaling that provide a framework for future studies to define the molecular mechanisms governing cell fate determination in human cells.
Cell lines and culture conditions
NPC HONE1 cells , mouse MCH903.1 cells containing human chromosome 3, three HONE1 hybrid cell lines (MCH4.4/4.5/4.6), and four TS cell lines (MCH4.5-1TS/4.5-2TS/4.6-1TS/4.6-2TS) were cultured as previously reported . Esophageal carcinoma cell line, SLMT1 and its hybrid cells, MCH3.11/3.22, with transferred chromosome 3 were cultured as previously reported . To minimize any possible change of gene expression influenced by culture conditions, environmental factors and genetic alterations in cultured cells , RNAs and proteins were obtained from early passages of hybrid cells and corresponding passages of parental cells for cell fusion. Human embryonic stem cells, H7, were obtained from the Stem Cell Core Facility of the University of Hong Kong and were maintained in Matrigel-covered plates and mTeSR1 culture medium, as suggested by the manufacturer (Stemcell Technologies, Vancouver, BC, Canada).
BIO (Stemgent, San Diego, USA) was stored and diluted following manufacturer’s instructions. Cells were grown in T25 flasks to 50% confluence and treated with BIO at concentrations of 0.5 μM, 1.0 μM, 2.5 μM, 5 μM, 10 μM, and 20 μM. Twenty-four hours later, both BIO-treated and mock-treated cells were washed in PBS and harvested for total RNA extraction.
Sphere formation assay
HONE1, HONE1 hybrids, and HONE hybrids with infected β-catenin shRNA cells were plated in T25 flasks, coated with 0.1% gelatin at 10–30 viable cells/ml and grown in Dulbecco’s modified eagle medium (DMEM) supplemented with 10% FBS. Cells were allowed to grow until spheres appeared. Three independent experiments were performed. After spheres formed, non-spheroid cells surrounding the spheres were scratched off and washed away with PBS daily in order to maintain the sphere growth. Only 50% of the culture medium was changed each time. The number of spheres was recorded under microscopy from 45 to 90 days after seeding cells. The pooled large and small spheres were collected for further RNA analysis.
RT2 Profiler PCR array analysis
Stem Cell Transcription Factors, Stem Cell Signaling, and Wnt Signaling Pathway PCR Arrays were obtained from SABIOSCIENCES (http://www.sabiosciences.com/Signal_Transduction.php), a Qiagen Company (Frederick, MD, USA). Multiple RNA expression (internal control and housekeeping genes) and genomic DNA contamination controls are included in these qPCR arrays. One μg of total RNA was used for the first strand cDNA synthesis reaction. All reaction procedures and data analyses were performed following the manufacturer’s manual (RT2 Profile PCR Array User Manual version 5.01) and provided analysis software (RT2 Profiler RCR Array Data Analysis version 3.5).
Infection of shRNAs
Both shRNAs scramble  (Addgene plasmid 1864) and β-catenin  (Addgene plasmid 19761), were obtained from Addgene (Cambridge, MA USA). HEK-293T cells were incubated at 37°C overnight and transfected with shRNA plasmid, psPAX2 packaging plasmid, pMD2.G envelope plasmid, and FuGENE in DMEM medium, following Addgene’s protocol. Lentiviral particle solution from cultured cells was harvested 48 hours later. HONE1 hybrid cells were plated in T25 flasks overnight and grown to approximately 80-90% confluence. The following day, 1 ml infection media was added in 3 ml culture medium containing 8 μg/ml polybrene for 48 hours. The selective drug puromycin was added 24 hours later. Infected cells were expanded and the third to fifth passages were collected for subsequent RNA and protein analyses.
HONE1 and HONE1 hybrid cells were transiently transfected using 1 μg of luciferase reporter plasmids (STOP) and control plasmids (SFOP) with the Lipofectamine 2000 (Invitrogen) transfection reagent according to manufacturer’s instructions. Cells were collected and lysed 48 hours post-transfection. The luciferase activity was assayed using the Luciferase Assay System (Promega). The β-galactosidase activity was assayed using Galacto-Light Plus System (Applied Biosystems, Life Technologies, Carlsbad, CA, USA). Both luciferase and β-galactosidase activities were measured using a TD20/20 luminometer (Turner Biosystems). STOP/SFOP ratio of luciferase reporter activities was normalized using β-galactosidase activities [47, 48].
RT-PCR and qPCR analyses
Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). One microgram of total RNA was reverse-transcribed with M-MLV Reverse Transcriptase (USB, Cleveland, OH, USA), as previously described . All RNAs were treated with DNAse. The primers and RT-PCR and qPCR conditions are summarized in Additional file 1: Table S2. Human GAPDH was used as an internal control for all RT-PCR reactions. For qPCR analysis, triplicate PCR reactions were performed using the LightCycler 480 Real-Time PCR Instrument (Roche Diagnositics GmbH, Mannheim, Germany).
Antibodies against CD24 and CD44 (BD Pharmingen) were used for FACS analyses. To sort HONE1 and HONE1 hybrid cells, the collected cells were resuspended in Pharmingen Stain Buffer and stained with antibodies for 30 min. The antibody-positive cells were sorted by the BD FACSAria Cell Sorter (San Jose, CA, USA), according to the protocols provided by the manufacturer.
Cell proliferation assay
The cell proliferation ability was studied using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay. Briefly, 0.5 × 103, 2.0 × 103, and 4.0 × 103 cells were seeded in 96-well plate. The cell proliferation rate was measured consecutively for 5 days. Thirty μl of 5 mg/ml filtered MTT solution (Sigma Chemical Co., St. Louis, MO) was added into the cells and incubated at 37°C for 4 hours. The absorbance at 570 nm was recorded with Multiskan FC Microplate Photometer (Thermo Scientific Inc., MA, USA).
Three-dimensional matrigel colony formation assays
A total of 1,000 cells was seeded on the top of Matrigel (BD Biosciences) and cultured for 14 days in 96-well plate. Images were captured at 4x and 10x magnification using Nikon Eclipse Ti inverted microscope (Nikon Instruments Inc., NY, USA) and analyzed with SPOT Advanced software (Diagnostic Instruments Inc., MI, USA). Colonies in 3 fields at 10x magnifications were counted and reported as the average number of colonies on the day 7 and 14.
Western blotting and immunofluorescence staining
Cells were seeded onto a 150 mm culture plate and were then scraped from the plate for Western blotting, which were performed as previously described . The primary antibodies for Western blot analyses are summarized in Additional file 1: Table S3. Cells for immunofluorescence staining of β-catenin were grown on glass coverslips and incubated with primary and secondary antibodies for overnight and one hour, respectively, and analyzed by confocal microscopy (LSM 710, Zeiss, Germany).
Animal assay and immunohistochemical staining
Both HONE1 and HONE1 hybrid cells were injected into nude mice as previously described [11, 12]. Tumors derived from both HONE1 and HONE1 hybrid cells were excised for both tissue culture in selective medium and paraffin-embedded for immunohistochemistry analysis using antibodies (β-catenin, E-cadherin, and Cyclin D1) (Additional file 1: Table S3), as described previously . All animal experiments were approved by the Government of Hong Kong Special Administrative Region and University of Hong Kong.
Cancer stem cells
Dulbecco’s modified eagle medium
Fibroblast growth factor
Microcell hybrid cell
Short hairpin RNA
Transforming growth factor-β
Tumor suppressor gene.
The authors thank Dr. Eric Stanbridge (University of California, Irvine) for helpful discussion and material support. The authors also thank Drs. David Sabatini and William Hahn for shRNAs from Addgene, the University of Hong Kong Li Ka Shing Faculty of Medicine Stem Cell Core Facility for stem cells, equipment access in the Core Facility for microscopy and FACS analyses, and the Department of Anatomy for access to the TD20/20 luminometer. This work was funded by the Research Grants Council Area of Excellence scheme in Hong Kong (AoE/M-06/08) to MLL and the University of Hong Kong Seed Funding Program for Basic Research (Project Codes: 201007159005 and 201111159142) to YC.
- Fodde R, Brabletz T: Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 2007, 19 (2): 150-158. 10.1016/j.ceb.2007.02.007.View ArticlePubMed
- Kikuchi A, Yamamoto H, Sato A: Selective activation mechanisms of Wnt signaling pathways. Trends Cell Biol. 2009, 19 (3): 119-129. 10.1016/j.tcb.2009.01.003.View ArticlePubMed
- Reya T, Clevers H: Wnt signalling in stem cells and cancer. Nature. 2005, 434 (7035): 843-850. 10.1038/nature03319.View ArticlePubMed
- ten Berge D, Kurek D, Blauwkamp T, Koole W, Maas A, Eroglu E, Siu RK, Nusse R: Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells. Nat Cell Biol. 2011, 13 (9): 1070-1075. 10.1038/ncb2314.View ArticlePubMed
- Dravid G, Ye Z, Hammond H, Chen G, Pyle A, Donovan P, Yu X, Cheng L: Defining the role of Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells. 2005, 23 (10): 1489-1501. 10.1634/stemcells.2005-0034.View ArticlePubMed
- Kielman MF, Rindapaa M, Gaspar C, van Poppel N, Breukel C, van Leeuwen S, Taketo MM, Roberts S, Smits R, Fodde R: Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat Genet. 2002, 32 (4): 594-605. 10.1038/ng1045.View ArticlePubMed
- Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 2010, 12 (5): 468-476. 10.1038/ncb2048.View ArticlePubMed
- Clevers H, Nusse R: Wnt/beta-catenin signaling and disease. Cell. 2012, 149 (6): 1192-1205. 10.1016/j.cell.2012.05.012.View ArticlePubMed
- Wray J, Hartmann C: WNTing embryonic stem cells. Trends Cell Biol. 2012, 22 (3): 159-168. 10.1016/j.tcb.2011.11.004.View ArticlePubMed
- Davidson KC, Adams AM, Goodson JM, McDonald CE, Potter JC, Berndt JD, Biechele TL, Taylor RJ, Moon RT: Wnt/beta-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4. Proc Natl Acad Sci USA. 2012, 109 (12): 4485-4490. 10.1073/pnas.1118777109.PubMed CentralView ArticlePubMed
- Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI, Stanbridge EJ: Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci USA. 1998, 95 (6): 3042-3047. 10.1073/pnas.95.6.3042.PubMed CentralView ArticlePubMed
- Cheng Y, Stanbridge EJ, Kong H, Bengtsson U, Lerman MI, Lung ML: A functional investigation of tumor suppressor gene activities in a nasopharyngeal carcinoma cell line HONE1 using a monochromosome transfer approach. Genes Chromosomes Cancer. 2000, 28 (1): 82-91. 10.1002/(SICI)1098-2264(200005)28:1<82::AID-GCC10>3.0.CO;2-8.View ArticlePubMed
- Sun Y, Hegamyer G, Cheng YJ, Hildesheim A, Chen JY, Chen IH, Cao Y, Yao KT, Colburn NH: An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad Sci USA. 1992, 89 (14): 6516-6520. 10.1073/pnas.89.14.6516.PubMed CentralView ArticlePubMed
- Sun Y, Hegamyer G, Colburn NH: Nasopharyngeal carcinoma shows no detectable retinoblastoma susceptibility gene alterations. Oncogene. 1993, 8 (3): 791-795.PubMed
- Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K, Yamanaka S: Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature. 2009, 460 (7259): 1132-1135. 10.1038/nature08235.PubMed CentralView ArticlePubMed
- Pajcini KV, Corbel SY, Sage J, Pomerantz JH, Blau HM: Transient inactivation of Rb and ARF yields regenerative cells from postmitotic mammalian muscle. Cell Stem Cell. 2010, 7 (2): 198-213. 10.1016/j.stem.2010.05.022.PubMed CentralView ArticlePubMed
- He S, Nakada D, Morrison SJ: Mechanisms of stem cell self-renewal. Annu Rev Cell Dev Biol. 2009, 25: 377-406. 10.1146/annurev.cellbio.042308.113248.View ArticlePubMed
- Damalas A, Ben-Ze'ev A, Simcha I, Shtutman M, Leal JF, Zhurinsky J, Geiger B, Oren M: Excess beta-catenin promotes accumulation of transcriptionally active p53. EMBO J. 1999, 18 (11): 3054-3063. 10.1093/emboj/18.11.3054.PubMed CentralView ArticlePubMed
- Kim NH, Kim HS, Kim NG, Lee I, Choi HS, Li XY, Kang SE, Cha SY, Ryu JK, Na JM: p53 and microRNA-34 are suppressors of canonical Wnt signaling. Sci Signal. 2011, 4 (197): ra71-10.1126/scisignal.2001744.PubMed CentralView ArticlePubMed
- Lee KH, Li M, Michalowski AM, Zhang X, Liao H, Chen L, Xu Y, Wu X, Huang J: A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells. Proc Natl Acad Sci USA. 2010, 107 (1): 69-74. 10.1073/pnas.0909734107.PubMed CentralView ArticlePubMed
- Lyashenko N, Winter M, Migliorini D, Biechele T, Moon RT, Hartmann C: Differential requirement for the dual functions of beta-catenin in embryonic stem cell self-renewal and germ layer formation. Nat Cell Biol. 2011, 13 (7): 753-761. 10.1038/ncb2260.PubMed CentralView ArticlePubMed
- Sokol SY: Maintaining embryonic stem cell pluripotency with Wnt signaling. Development. 2011, 138 (20): 4341-4350. 10.1242/dev.066209.PubMed CentralView ArticlePubMed
- Wray J, Kalkan T, Gomez-Lopez S, Eckardt D, Cook A, Kemler R, Smith A: Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat Cell Biol. 2011, 13 (7): 838-845. 10.1038/ncb2267.PubMed CentralView ArticlePubMed
- Yi F, Pereira L, Hoffman JA, Shy BR, Yuen CM, Liu DR, Merrill BJ: Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal. Nat Cell Biol. 2011, 13 (7): 762-770. 10.1038/ncb2283.PubMed CentralView ArticlePubMed
- Merrill BJ: Develop-WNTs in somatic cell reprogramming. Cell Stem Cell. 2008, 3 (5): 465-466. 10.1016/j.stem.2008.10.011.View ArticlePubMed
- Katoh M: WNT signaling pathway and stem cell signaling network. Clin Cancer Res. 2007, 13 (14): 4042-4045. 10.1158/1078-0432.CCR-06-2316.View ArticlePubMed
- Lluis F, Pedone E, Pepe S, Cosma MP: Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion. Cell Stem Cell. 2008, 3 (5): 493-507. 10.1016/j.stem.2008.08.017.View ArticlePubMed
- van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP: The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002, 111 (2): 241-250. 10.1016/S0092-8674(02)01014-0.View ArticlePubMed
- Chen T, Yuan D, Wei B, Jiang J, Kang J, Ling K, Gu Y, Li J, Xiao L, Pei G: E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells. 2010, 28 (8): 1315-1325. 10.1002/stem.456.View ArticlePubMed
- Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL: Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell. 2011, 145 (6): 926-940. 10.1016/j.cell.2011.04.029.PubMed CentralView ArticlePubMed
- Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic stem cell lines derived from human blastocysts. Science. 1998, 282 (5391): 1145-1147.View ArticlePubMed
- Cheng Y, Chakrabarti R, Garcia-Barcelo M, Ha TJ, Srivatsan ES, Stanbridge EJ, Lung ML: Mapping of nasopharyngeal carcinoma tumor-suppressive activity to a 1.8-megabase region of chromosome band 11q13. Genes Chromosomes Cancer. 2002, 34 (1): 97-103. 10.1002/gcc.10048.View ArticlePubMed
- Lung HL, Cheung AK, Ko JM, Cheng Y, Stanbridge EJ, Lung ML: Deciphering the molecular genetic basis of NPC through functional approaches. Semin Cancer Biol. 2012, 22 (2): 87-95. 10.1016/j.semcancer.2011.11.002.View ArticlePubMed
- Cheng Y, Ko JM, Lung HL, Lo PH, Stanbridge EJ, Lung ML: Monochromosome transfer provides functional evidence for growth-suppressive genes on chromosome 14 in nasopharyngeal carcinoma. Genes Chromosomes Cancer. 2003, 37 (4): 359-368. 10.1002/gcc.10228.View ArticlePubMed
- Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH: Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med. 2004, 10 (1): 55-63. 10.1038/nm979.View ArticlePubMed
- Lo PH, Leung AC, Kwok CY, Cheung WS, Ko JM, Yang LC, Law S, Wang LD, Li J, Stanbridge EJ: Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene. 2007, 26 (1): 148-157. 10.1038/sj.onc.1209767.View ArticlePubMed
- Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T: Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell. 2002, 111 (2): 251-263. 10.1016/S0092-8674(02)01015-2.View ArticlePubMed
- Lowry WE, Blanpain C, Nowak JA, Guasch G, Lewis L, Fuchs E: Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells. Genes Dev. 2005, 19 (13): 1596-1611. 10.1101/gad.1324905.PubMed CentralView ArticlePubMed
- Luis TC, Naber BA, Roozen PP, Brugman MH, de Haas EF, Ghazvini M, Fibbe WE, van Dongen JJ, Fodde R, Staal FJ: Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. Cell Stem Cell. 2011, 9 (4): 345-356. 10.1016/j.stem.2011.07.017.View ArticlePubMed
- Ocana OH, Corcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, Barrallo-Gimeno A, Cano A, Nieto MA: Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer prrx1. Cancer Cell. 2012, 22 (6): 709-724. 10.1016/j.ccr.2012.10.012.View ArticlePubMed
- Li R, Liang J, Ni S, Zhou T, Qing X, Li H, He W, Chen J, Li F, Zhuang Q: A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell. 2010, 7 (1): 51-63. 10.1016/j.stem.2010.04.014.View ArticlePubMed
- Soncin F, Mohamet L, Eckardt D, Ritson S, Eastham AM, Bobola N, Russell A, Davies S, Kemler R, Merry CL: Abrogation of E-cadherin-mediated cell-cell contact in mouse embryonic stem cells results in reversible LIF-independent self-renewal. Stem Cells. 2009, 27 (9): 2069-2080. 10.1002/stem.134.View ArticlePubMed
- Cheung AKL, Phoon YP, Lung HL, Ko JMY, Cheng Y, Lung ML: Roles of tumor suppressor signaling on reprogramming and stemness transition in somatic cells. Future aspects of tumor suppressor gene. Edited by: Cheng Y. 2013, Croatia: InTech, 75-96.View Article
- Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, Li GY, Wen DS, Li YP: Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA. 1989, 86 (23): 9524-9528. 10.1073/pnas.86.23.9524.PubMed CentralView ArticlePubMed
- Sarbassov DD, Guertin DA, Ali SM, Sabatini DM: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005, 307 (5712): 1098-1101. 10.1126/science.1106148.View ArticlePubMed
- Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S: CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature. 2008, 455 (7212): 547-551. 10.1038/nature07179.PubMed CentralView ArticlePubMed
- Atcha FA, Syed A, Wu B, Hoverter NP, Yokoyama NN, Ting JH, Munguia JE, Mangalam HJ, Marsh JL, Waterman ML: A unique DNA binding domain converts T-cell factors into strong Wnt effectors. Mol Cell Biol. 2007, 27 (23): 8352-8363. 10.1128/MCB.02132-06.PubMed CentralView ArticlePubMed
- Arce L, Yokoyama NN, Waterman ML: Diversity of LEF/TCF action in development and disease. Oncogene. 2006, 25 (57): 7492-7504. 10.1038/sj.onc.1210056.View ArticlePubMed
- Cheung AK, Lung HL, Ko JM, Cheng Y, Stanbridge EJ, Zabarovsky ER, Nicholls JM, Chua D, Tsao SW, Guan XY: Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma. Proc Natl Acad Sci USA. 2009, 106 (34): 14478-14483. 10.1073/pnas.0900198106.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.